GIANNARELLI, DIANA
 Distribuzione geografica
Continente #
NA - Nord America 256
EU - Europa 254
AS - Asia 46
AF - Africa 1
SA - Sud America 1
Totale 558
Nazione #
US - Stati Uniti d'America 255
GB - Regno Unito 78
IE - Irlanda 62
IT - Italia 40
CN - Cina 28
RU - Federazione Russa 20
SE - Svezia 12
SG - Singapore 12
UA - Ucraina 12
DE - Germania 9
FI - Finlandia 8
FR - Francia 7
ES - Italia 3
IN - India 3
CH - Svizzera 2
AM - Armenia 1
BE - Belgio 1
BO - Bolivia 1
CA - Canada 1
PH - Filippine 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 558
Città #
Southend 75
Dublin 61
Fairfield 33
Santa Clara 27
Ashburn 26
Houston 23
Wilmington 20
Woodbridge 18
Cambridge 16
Siena 15
Chandler 13
Seattle 12
Singapore 12
Jacksonville 10
New York 6
Princeton 6
Beijing 5
Venezia 5
Florence 4
Helsinki 4
Nanjing 4
Düsseldorf 3
Málaga 3
Shanghai 3
Ann Arbor 2
Boardman 2
Changsha 2
Falls Church 2
Hounslow 2
Jinan 2
Milan 2
Nanchang 2
Rome 2
Tianjin 2
Zurich 2
Arezzo 1
Brussels 1
Dearborn 1
Espoo 1
Frankfurt am Main 1
Jiaxing 1
Johannesburg 1
La Paz 1
Lanzhou 1
Lappeenranta 1
London 1
Los Angeles 1
Menderes 1
Moscow 1
Newark 1
Ningbo 1
Ottawa 1
Perugia 1
San Diego 1
San Francisco 1
San Mateo 1
Vicenza 1
Yerevan 1
Totale 449
Nome #
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy) 223
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme 186
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study 66
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 42
Safety and immunobiological activity of guadecitabine sequenced with ipilimumab in metastatic melanoma patients: The phase Ib NIBIT-M4 study 38
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 13
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 5
Totale 573
Categoria #
all - tutte 2.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 0 0 0 0 9 22 15 10 5 4 2
2020/202159 4 3 5 3 5 11 0 8 6 5 3 6
2021/202240 6 3 1 0 2 1 1 1 3 5 5 12
2022/202364 3 5 9 6 7 7 3 7 5 3 8 1
2023/2024108 10 2 11 7 4 23 40 2 2 1 2 4
2024/202588 4 7 17 9 30 21 0 0 0 0 0 0
Totale 573